BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
76.80
-0.56 (-0.72%)
At close: Nov 17, 2026, 4:00 PM EST
76.76
-0.04 (-0.05%)
After-hours: Nov 17, 2026, 5:52 PM EST

BridgeBio Pharma Statistics

Total Valuation

BBIO has a market cap or net worth of $14.96 billion. The enterprise value is $16.80 billion.

Market Cap14.96B
Enterprise Value 16.80B

Important Dates

The last earnings date was Thursday, October 29, 2026, after market close.

Earnings Date Oct 29, 2026
Ex-Dividend Date n/a

Share Statistics

BBIO has 194.80 million shares outstanding. The number of shares has increased by 2.39% in one year.

Current Share Class 194.80M
Shares Outstanding 194.80M
Shares Change (YoY) +2.39%
Shares Change (QoQ) +0.12%
Owned by Insiders (%) 3.95%
Owned by Institutions (%) 95.71%
Float 163.01M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 15.75
Forward PS 10.13
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 17.70
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.09

Current Ratio 2.09
Quick Ratio 1.96
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -1.66

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -13.97%
Return on Invested Capital (ROIC) -17.67%
Return on Capital Employed (ROCE) -29.81%
Weighted Average Cost of Capital (WACC) 8.59%
Revenue Per Employee $871,465
Profits Per Employee -$545,737
Employee Count1,085
Asset Turnover 0.60
Inventory Turnover 1.27

Taxes

In the past 12 months, BBIO has paid $1.11 million in taxes.

Income Tax 1.11M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +15.68% in the last 52 weeks. The beta is 0.94, so BBIO's price volatility has been similar to the market average.

Beta (5Y) 0.94
52-Week Price Change +15.68%
50-Day Moving Average 70.07
200-Day Moving Average 72.69
Relative Strength Index (RSI) 59.54
Average Volume (20 Days) 2,975,165

Short Selling Information

The latest short interest is 20.85 million, so 10.70% of the outstanding shares have been sold short.

Short Interest 20.85M
Short Previous Month 20.00M
Short % of Shares Out 10.70%
Short % of Float 12.79%
Short Ratio (days to cover) 7.35

Income Statement

In the last 12 months, BBIO had revenue of $945.54 million and -$592.13 million in losses. Loss per share was -$3.04.

Revenue945.54M
Gross Profit 892.00M
Operating Income -353.11M
Pretax Income -576.47M
Net Income -592.13M
EBITDA -348.36M
EBIT -353.11M
Loss Per Share -$3.04
Full Income Statement

Balance Sheet

The company has $1.54 billion in cash and $3.38 billion in debt, with a net cash position of -$1.84 billion or -$9.44 per share.

Cash & Cash Equivalents 1.54B
Total Debt 3.38B
Net Cash -1.84B
Net Cash Per Share -$9.44
Equity (Book Value) -1.65B
Book Value Per Share -13.29
Working Capital 1.07B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$368.97 million and capital expenditures -$835,000, giving a free cash flow of -$369.81 million.

Operating Cash Flow -368.97M
Capital Expenditures -835,000
Depreciation & Amortization 4.74M
Net Borrowing 576.89M
Free Cash Flow -369.81M
FCF Per Share -$1.90
Full Cash Flow Statement

Margins

Gross margin is 94.34%, with operating and profit margins of -37.34% and -59.84%.

Gross Margin 94.34%
Operating Margin -37.34%
Pretax Margin -60.97%
Profit Margin -59.84%
EBITDA Margin -36.84%
EBIT Margin -37.34%
FCF Margin n/a

Dividends & Yields

BBIO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -2.39%
Shareholder Yield -2.39%
Earnings Yield -3.95%
FCF Yield -2.48%
Dividend Details

Analyst Forecast

The average price target for BBIO is $107.00, which is 39.32% higher than the current price. The consensus rating is "Buy".

Price Target $107.00
Price Target Difference 39.32%
Analyst Consensus Buy
Analyst Count 22
Revenue Growth Forecast (3Y) 72.28%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

BBIO has an Altman Z-Score of -0.04 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -0.04
Piotroski F-Score 2